Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial (Q50109825)
Jump to navigation
Jump to search
scientific article published on 9 December 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial |
scientific article published on 9 December 2016 |
Statements
1 reference
Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial (English)
1 reference
Reza Rahmanzadeh
Sanaz Eftekhari
Ali Shahbazi
Mohammad-Reza Khodaei Ardakani
Ramin Rahmanzade
9 December 2016
1 reference